Cytotoxic T-lymphocyte (CTL) and Natural killer (NK) cell (CTL/NK cell)

Cytotoxic T-lymphocytes (CTLs) and Natural Killer (NK) cells are the primary effector cells of the immune system responsible for the surveillance and elimination of virally infected or neoplastic cells (StatPearls: NK Cells, 2023; StatPearls: Cytotoxic T Cells, 2023). CTLs are CD8+ adaptive immune cells that recognize specific peptide antigens presented on MHC class I molecules, while NK cells are innate lymphocytes that respond to "missing self" or stress-induced ligands (Janeway's Immunobiology, 9th ed.). Both populations execute their cytotoxic function through the directed exocytosis of granules containing perforin and granzymes, which trigger apoptosis in the target cell (Nature Reviews Immunology, 2020). In the context of modern medicine, these cells are not molecular targets themselves but are the functional units modulated by immunotherapies such as checkpoint inhibitors (e.g., Nivolumab) and cytokines (e.g., IL-2) to restore or enhance anti-tumor immunity (NCI: Checkpoint Inhibitors, 2024). Therapeutic strategies also include the adoptive transfer of these cells, often genetically modified with Chimeric Antigen Receptors (CARs), to provide targeted destruction of cancer cells (Nature Reviews Clinical Oncology, 2023).

Other names

CD8+ T-lymphocyteKiller T-cellNK cellLarge granular lymphocyteCytotoxic effector cell

Drugs modulate these cells by blocking inhibitory checkpoints (e.g., PD-1, CTLA-4), providing stimulatory cytokines (e.g., IL-2), or using them as effectors for antibody-dependent cellular cytotoxicity (ADCC) (Nature Reviews Immunology, 2020; NCI, 2024).